Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to CorVel Corp’s (NASDAQ: CRVL) SEC filings, offering detailed insight into the company’s governance, compensation, shareholder matters, and financial reporting. As a Delaware corporation with common stock listed on the NASDAQ Global Select Market, CorVel files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and other required documents with the U.S. Securities and Exchange Commission.
CorVel’s Form 8-K filings include announcements of quarterly and year-to-date financial results, often furnishing press releases that discuss revenues, income from operations, and net income, as well as commentary on technology initiatives, acquisitions of technology assets for its CERIS division, and other material events. These current reports can help investors understand how developments such as AI-driven platform enhancements, stock splits, or workforce programs relate to the company’s financial condition.
The company’s definitive proxy statement (DEF 14A) provides information on board structure, director elections, committee composition, environmental, social and governance practices, executive compensation, equity incentive plans, and shareholder voting procedures. It also describes the matters submitted to stockholders at the annual meeting, such as the election of directors, ratification of the independent registered public accounting firm, and approval of stock incentive plans.
Through this filings page, users can review CorVel’s historical and current SEC documents, including Forms 10-K and 10-Q for comprehensive financial statements and risk factor discussions, as well as Form 4 insider transaction reports when available. Stock Titan’s tools surface real-time updates from EDGAR and apply AI-powered summaries to help explain the key points in lengthy filings, so readers can more quickly understand segment performance, governance decisions, compensation structures, and other disclosures that shape CorVel’s risk management business.
CorVel Corp CEO & President Michael G. Combs reported multiple stock option exercises and related share withholdings dated January 5, 2026. He exercised non-qualified stock options covering 27,750, 501 and 156 shares of common stock at exercise prices of $51.997, $39.827 and $34.437 per share, respectively. According to the footnote, shares were delivered to pay the option exercise price and/or tax liabilities incident to these exercises, including transactions where 21,175 and 2,306 shares of common stock, among smaller amounts, were withheld. After these transactions, he directly owned 48,773 shares of common stock and 22,871 non-qualified stock options.
CorVel Corp director Steve Hamerslag reported a charitable gift of 7,000 shares of common stock on 12/11/2025. The transaction was coded as a gift and carried a reported price of $0.0 per share, indicating it was not a market sale.
After this donation, Hamerslag beneficially owns 307,000 CorVel shares directly. The footnote explains that the shares were gifted to charity DAFgiving360.
CorVel Corporation (CRVL) director stock sale reported. A company director reported selling 3,247 shares of CorVel common stock on 11/07/2025 in an open-market transaction coded "S" for sale. The weighted average sale price was $76.20 per share, with individual trades executed between $76.10 and $76.27. After this transaction, the reporting person beneficially owns 111,798 CorVel shares in direct ownership.
CorVel Corp (CRVL) executive vice president for Risk Management Services, Mark Bertels, reported an insider transaction involving company stock. On 11/19/2025, he exercised a non-qualified stock option to buy 1,200 shares of common stock at an exercise price of $34.437 per share, then sold 1,200 shares of common stock at a price of $72.35 per share on the same date. After these transactions, he directly owns 2,594 shares of CorVel common stock and holds no remaining derivative securities from this option grant. The option was originally structured to vest 25% one year after grant with the balance vesting in 36 equal monthly installments.
CorVel (CRVL) director reported open‑market sales on a Form 4. On 11/10/2025, 210 shares of common stock were sold at $76.27, leaving 122,121 shares beneficially owned directly. On 11/11/2025, a further 7,076 shares were sold at $76.94, bringing direct beneficial ownership to 115,045 shares.
The filing indicates a single reporting person and direct ownership of all reported holdings.
CorVel Corp (CRVL) reported a Form 4 for Vice President of Accounting Jennifer Yoss. On 11/06/2025, she was granted 3,500 non‑qualified stock options with an exercise price of $75.36, expiring on 11/06/2030.
The options will vest based on achievement of performance criteria relating to earnings growth. Following the grant, she beneficially owned 3,500 derivative securities held directly.
CorVel Corp (CRVL) disclosed that Chief Information Officer Maxim Shishin received a performance-based non-qualified stock option grant. The award covers 4,000 options with an exercise price of $75.36, granted on 11/06/2025 and expiring on 11/06/2030. Vesting is tied to achieving certain performance criteria relating to earnings growth. The filing lists the ownership of the derivative securities as direct.
CorVel (CRVL) reported an insider equity grant. The company’s EVP of Risk Management Services received a non-qualified stock option for 4,000 shares at an exercise price of $75.36 on 11/06/2025, coded “A” for award. The option expires on 11/06/2030 and vests based on achieving performance criteria related to earnings growth. Following the grant, 4,000 derivative securities were beneficially owned, held directly.
CorVel Corporation filed a Form S-8 registering 1,775,459 shares of common stock for issuance under the CorVel Corporation 2025 Stock Incentive Plan. The plan was approved by stockholders on August 7, 2025. This registration supports equity-based compensation, allowing the company to grant options and other awards to employees, directors, and eligible participants under the plan.
Form S-8 registrations are administrative and do not, by themselves, represent a capital raise or a public sale. Instead, they make plan shares available for future grants consistent with the plan’s terms and applicable securities laws.
CorVel Corporation reported stronger quarterly results for the three months ended September 30, 2025. Revenue reached $239,643,000, up 7% year over year, as network solutions activity expanded with existing customers. Net income was $27,906,000 and diluted EPS was $0.54, compared with $0.45 a year ago.
Profitability improved: gross margin rose to 24.3% from 22.6%, while general and administrative costs held near 9% of revenue. Segment mix was 62.9% patient management ($150,795,000) and 37.1% network solutions ($88,848,000). Operating cash flow for the first six months totaled $80,035,000, supporting cash and equivalents of $207,453,000.
The company continued buybacks, repurchasing 143,774 shares for approximately $12.8 million in the quarter and 230,879 shares for $22.5 million year-to-date. Shares outstanding were 51,293,374 as of September 30, 2025. Management also noted a recent technology asset acquisition to enhance bill review capabilities.
FAQ
What is the current stock price of Corvel (CRVL)?
What is the market cap of Corvel (CRVL)?
